ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,459Medicare Part D Prescriptions Filled, Including Refills

Rank: 645 out of 2170

$435K Total Retail Price of All Prescriptions

Rank: 590 out of 2170

277 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 277 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 3,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LISINOPRIL 365 202 1 3
OMEPRAZOLE 287 151 2 2
SIMVASTATIN 217 164 3 1
LEVOTHYROXINE SODIUM 202 104 4 5
ALENDRONATE SODIUM 196 115 5 36
METFORMIN HCL 185 92 6 8
FUROSEMIDE 176 98 7 6
FENOFIBRATE 170 77 8 57
CITALOPRAM HBR 144 31 9 19
AMLODIPINE BESYLATE 129 80 10 4
HYDROCHLOROTHIAZIDE 124 63 11 9
ATORVASTATIN CALCIUM 122 61 12 12
HYDROCODONE-ACETAMINOPHEN 120 87 S3 13 7
ZOLPIDEM TARTRATE 116 73 14 17
GABAPENTIN 109 38 15 14
SERTRALINE HCL 106 73 16 25
PRAVASTATIN SODIUM 106 67 16 11
NEXIUM 100 38 18 22
METOPROLOL SUCCINATE 96 51 19 13
LOVASTATIN 95 48 20 34
WARFARIN SODIUM 94 60 21 15
POTASSIUM CHLORIDE 92 66 22 16
ATENOLOL 83 44 23 23
FLUTICASONE PROPIONATE 83 50 23 30
SYMBICORT 77 37 25 150
CRESTOR 74 52 26 24
INSULIN SYRINGE 69 29 27 113
COMBIVENT 67 38 28 112
LOSARTAN-HYDROCHLOROTHIAZIDE 61 52 29 42
MELOXICAM 60 30 30 28
RISPERIDONE 59 0 31 73
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 39 32 20
PROAIR HFA 56 15 33 43
NOVOLOG 55 31 34 98
FLUOXETINE HCL 54 42 35 59
METOPROLOL TARTRATE 52 36 36 10
CLOPIDOGREL 50 22 37 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.